Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,054 public trials 1,183 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy

NCT02310230

Conditions: Adenocarcinoma, Barrett Esophagus, Biliary Tract Diseases, +20 more
Locations: University of Vermont Medical Center Burlington, Vermont, United States

View Trial Details

Completed

Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

NCT05690451

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Bundang Hospital Seongnam, Korea (the Republic Of), South Korea

Asan Medical Center Seoul, Korea (the Republic Of), South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

NCT04518852

Conditions: Adenocarcinoma, Antineoplastic Agents, Carcinoma, +13 more
Locations: Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China

View Trial Details

Completed

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

NCT04919642

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +7 more
Locations: Providence Cancer Center Anchorage, Alaska, United States

City of Hope Duarte, California, United States

University of California, Los Angeles, School of Medicine Santa Monica, California, United States

USO Oncology Network- Rocky Mountain Cancer Centers Denver, Colorado, United States

View all 32 locations

View Trial Details

Completed

FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1

NCT05518071

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: Leiden University Medical Center Leiden, Netherlands

View Trial Details

Completed

A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

NCT03418922

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Eisai Trial Site 1 Kashiwa, Chiba, Japan

Eisai Trial Site 6 Iizuka, Fukuoka, Japan

Eisai Trial Site 3 Kawasaki, Kanagawa, Japan

Eisai Trial Site 4 Sayama, Osaka, Japan

View Trial Details

Completed

Novel Prognostic Markers in Renal Cancer

NCT01002937

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom

View Trial Details

Completed

RFA Versus SBRT for Recurrent Small HCC

NCT04047173

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Completed

TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma

NCT06232759

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Jian-Hong Zhong Nanning, Guangxi, China

View Trial Details

Completed

Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib

NCT02759835

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions